[Translational research on adrenomedullin].
Shimosawa
Tatsuo
T
Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Tokyo.
Fujita
Toshiro
T
D053607:Adrenomedullin; D000818:Animals; D000959:Antihypertensive Agents; D000975:Antioxidants; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D015316:Genetic Therapy; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000628:therapy; D045283:Natriuretic Agents; D015260:Neprilysin / Q000037:antagonists & inhibitors; D010455:Peptides / Q000235:genetics / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use; D014665:Vasodilator Agents
D000959:Antihypertensive Agents; D000975:Antioxidants; D004791:Enzyme Inhibitors; D045283:Natriuretic Agents; D010455:Peptides; D011725:Pyridines; D013841:Thiazepines; D014665:Vasodilator Agents; D053607:Adrenomedullin; C106266:omapatrilat; D015260:Neprilysin